R R KABEL LTD Q2 RESULTS
Kiran Mazumdar-Shaw on Biocon Q1 results: Our biz must be viewed on core EBITDA as R&D spend is an integral part of future growth
Global biopharmaceuticals company Biocon on Wednesday reported 23 per cent rise in revenue for the first quarter of financial year 2023, at Rs 2,217 crore. "Our biz must be viewed on core EBITDA as R&D spend is an integra...
'Q2 earnings recovery remains uncertain going forward'
Prabodh Agarwal, HoR, IIFL Institutional Equities spoke to ET Now about the Q2 earnings disappointment. He said that earnings recovery remain uncertain going forward. Check out the video for more information.'Q2 earnings recovery remains uncertain going forward'
Facebook records slowest revenue growth in 2 years
The world's largest internet social network said revenue rose to $3.54 billion from $2.50 billion in first quarter of 2015. Revenue from advertising was $3.32 billion, a 46 per cent rise from a year earlier. Net income attributable to stockholders fell to $509 million, or 18 cents per share, in the ...
